ArticleJournal of translational medicine2025

Sinensetin serves as an AMPK activator to inhibit RANKL-induced osteoclastogenesis via osteoclast cytoskeleton reorganization.

Yijie Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.